慢性乙型和丙型病毒性肝炎中的树突状细胞：受害者还是守护天使？ - Suppr

Suppr

超能文献

Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?

作者信息

Woltman A M, Boonstra A, Janssen H L A

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

出版信息

Gut. 2010 Jan;59(1):115-25. doi: 10.1136/gut.2009.181040.

DOI:10.1136/gut.2009.181040

PMID:20007959

Abstract

摘要

相似文献

Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?慢性乙型和丙型病毒性肝炎中的树突状细胞：受害者还是守护天使？

Gut. 2010 Jan;59(1):115-25. doi: 10.1136/gut.2009.181040.

Measuring immunity in viral hepatitis.测量病毒性肝炎中的免疫力。

J Gastroenterol. 2004 Aug;39(8):709-16. doi: 10.1007/s00535-004-1395-9.

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.嗜肝病毒的慢性感染：细胞免疫反应受损机制

Semin Liver Dis. 2007 May;27(2):152-60. doi: 10.1055/s-2007-979468.

[Clinical significance of cytokine level and T-cell lymphocyte response to B and C hepatic viral antigens in patients with type C and B+C hepatitis receiving antiviral therapy].[接受抗病毒治疗的丙型和乙型加丙型肝炎患者细胞因子水平及T淋巴细胞对B和C型肝病毒抗原反应的临床意义]

Klin Med (Mosk). 2007;85(7):63-6.

[Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].[自身免疫性甲状腺病变作为慢性病毒性肝炎干扰素治疗的并发症]

Ter Arkh. 1999;71(12):69-72.

Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.诱导针对肝脏提取蛋白的口服免疫调节以治疗慢性乙型肝炎和丙型肝炎：一项I期临床试验结果

Liver Int. 2004 Aug;24(4):295-307. doi: 10.1111/j.1478-3231.2004.0935.x.

Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.丙型肝炎病毒感染中的免疫反应及丙型肝炎病毒持续存在的机制。

J Gastroenterol Hepatol. 2008 Oct;23(10):1473-82. doi: 10.1111/j.1440-1746.2008.05475.x. Epub 2008 Aug 28.

A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.一种提高CD8+ T细胞与MHC-肽复合物四聚体染色效率的方法：在监测乙型和丙型肝炎治疗期间细胞毒性T淋巴细胞活性中的治疗应用

J Immunol Methods. 2004 Feb 1;285(1):71-87. doi: 10.1016/j.jim.2003.11.005.

GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.丙型肝炎病毒C型驱动的HIV/HCV合并感染中的保护作用：γ干扰素和树突状细胞激活的潜在作用

Gastroenterology. 2008 May;134(5):1631-3; author reply 1633. doi: 10.1053/j.gastro.2008.03.070.

Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.树突状细胞与T细胞相互作用中的选择性功能缺陷是慢性乙型肝炎病毒感染的关键机制。

J Viral Hepat. 2004 May;11(3):217-24. doi: 10.1111/j.1365-2893.2004.00497.x.

引用本文的文献

HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stage.根据患者的临床阶段，乙肝病毒（HBV）和乙肝表面抗原（HBsAg）会显著重塑树突状细胞（DCs）的表型、功能和代谢。

Hepatol Commun. 2025 Jan 29;9(2). doi: 10.1097/HC9.0000000000000625. eCollection 2025 Feb 1.

Chitosan Nanovaccines as Efficient Carrier Adjuvant System for IL-12 with Enhanced Protection Against HBV.壳聚糖纳米疫苗作为高效载体佐剂系统，增强了对乙型肝炎病毒的保护作用。

Int J Nanomedicine. 2021 Jul 21;16:4913-4928. doi: 10.2147/IJN.S317113. eCollection 2021.

Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures.设计用于治愈慢性乙型肝炎的下一代治疗性疫苗：聚焦抗原呈递、疫苗特性及疗效评估指标

Clin Transl Immunology. 2021 Jan 15;10(1):e1232. doi: 10.1002/cti2.1232. eCollection 2021.

Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.乙型肝炎病毒利用C型凝集素受体劫持浆细胞样树突状细胞、常规树突状细胞1型和常规树突状细胞2型。

Clin Transl Immunology. 2020 Dec 8;9(12):e1208. doi: 10.1002/cti2.1208. eCollection 2020.

Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.慢性乙型肝炎病毒感染中 T 细胞功能障碍的发病机制及相关治疗方法。

Front Immunol. 2020 May 12;11:849. doi: 10.3389/fimmu.2020.00849. eCollection 2020.

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.循环和肝脏中的 BDCA1+、BDCA2+ 和 BDCA3+ 树突状细胞在慢性 HBV 感染患者中被不同程度地破坏。

Front Immunol. 2019 Feb 4;10:112. doi: 10.3389/fimmu.2019.00112. eCollection 2019.

A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.乙肝病毒包膜蛋白跨膜区的一种新型T细胞表位在树突状细胞扩增时产生反应。

Arch Virol. 2019 Feb;164(2):483-495. doi: 10.1007/s00705-018-4095-0. Epub 2018 Nov 10.

HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo.HBV 衍生合成长肽可在慢性 HBV 患者体外增强 CD4+和 CD8+ T 细胞反应。

J Infect Dis. 2018 Feb 14;217(5):827-839. doi: 10.1093/infdis/jix614.

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.聚乙二醇化干扰素α-2a在慢性HBV感染且未发生HBsAg血清学转换的患者中触发自然杀伤细胞功能和特异性T细胞反应。

PLoS One. 2016 Jun 27;11(6):e0158297. doi: 10.1371/journal.pone.0158297. eCollection 2016.

Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.乙肝病毒表面抗原通过可溶性CD14依赖机制激活髓样树突状细胞。

J Virol. 2016 Jun 24;90(14):6187-6199. doi: 10.1128/JVI.02903-15. Print 2016 Jul 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验